Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans‐Atlantic, multicenter cross‐sectional cohort study
Pediatric Blood & Cancer · 2023
DOI: 10.1002/pbc.30412 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Pediatric Blood & Cancer, 2023. Verfasst von Marinka L F Hol und 18 weiteren Autor:innen. Beteiligte Einrichtung: Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands. Hauptthemen laut MEDLINE: Head and Neck Neoplasms, Rhabdomyosarcoma, Embryonal, Rhabdomyosarcoma. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Cancer Research UK.
Abstract (Originalsprache)
Background
The four different local therapy strategies used for head and neck rhabdomyosarcoma (HNRMS) include proton therapy (PT), photon therapy (RT), surgery with radiotherapy (Paris‐method), and surgery with brachytherapy (AMORE). Local control and survival is comparable; however, the impact of these different treatments on facial deformation is still poorly understood. This study aims to quantify facial deformation and investigates the differences in facial deformation between treatment modalities.
Methods
Across four European and North American institutions, HNRMS survivors treated between 1990 and 2017, more than 2 years post treatment, had a 3D photograph taken. Using dense surface modeling, we computed facial signatures for each survivor to show facial deformation relative to 35 age–sex–ethnicity‐matched controls. Additionally, we computed individual facial asymmetry.
Findings
A total of 173 HNRMS survivors were included, survivors showed significantly reduced facial growth ( p < .001) compared to healthy controls. Partitioned by tumor site, there was reduced facial growth in survivors with nonparameningeal primaries ( p = .002), and parameningeal primaries ( p ≤.001), but not for orbital primaries ( p = .080) All patients were significantly more asymmetric than healthy controls, independent of treatment modality ( p ≤ .001). There was significantly more facial deformation in orbital patients when comparing RT to AMORE ( p = .046). In survivors with a parameningeal tumor, there was significantly less facial deformation in PT when compared to RT ( p = .009) and Paris‐method ( p = .007).
Interpretation
When selecting optimal treatment, musculoskeletal facial outcomes are an expected difference between treatment options. These anticipated differences are currently based on clinicians’ bias, expertise, and experience. These data supplement clinician judgment with an objective analysis highlighting the impact of patient age and tumor site between existing treatment options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Princess Maxima Center for Pediatric Oncology, Utrecht, The Netherlands.
- Department of Otorhinolaryngology, University of Utrecht, Utrecht, The Netherlands.
- Department of Maxillofacial Surgery, Amsterdam UMC, Duivendrecht, The Netherlands.
- Department of Radiation Oncology, University of Florida Proton Therapy Institute, Jacksonville, Florida, USA.
- Department of Pediatric Oncology, Great Ormond Street Hospital, NHS Foundation Trust, London, UK.
- Department of Plastic Surgery, Institute Gustave Roussy, Paris, France.
ORCID-Profile: Marinka L F Hol, Daniel J Indelicato, Mark N Gaze, Raquel Dávila Fajardo
Förderung
- Cancer Research UK
Zitieren
APA
Hol, M. L. F., Indelicato, D. J., Slater, O., Kolb, F., Hewitt, R. J., Ong, J., Becking, A. G., Gains, J., Bradley, J., Sandler, E., Gaze, M. N., Pieters, B., Mandeville, H., Fajardo, R. D., Schoot, R., Merks, J. H. M., Hammond, P., Smeele, L. E., & Suttie, M. (2023). Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans‐Atlantic, multicenter cross‐sectional cohort study. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.30412
Vancouver
Hol MLF, Indelicato DJ, Slater O, Kolb F, Hewitt RJ, Ong J, et al. Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans‐Atlantic, multicenter cross‐sectional cohort study. Pediatric Blood & Cancer. 2023. doi:10.1002/pbc.30412
BibTeX
@article{Hol2023,
author = {Hol, Marinka L F and Indelicato, Daniel J and Slater, Olga and Kolb, Frederic and Hewitt, Richard J and Ong, Juling and Becking, Alfred G and Gains, Jenny and Bradley, Julie and Sandler, Eric and Gaze, Mark N and Pieters, Bradley and Mandeville, Henry and Fajardo, Raquel Dávila and Schoot, Reineke and Merks, Johannes H M and Hammond, Peter and Smeele, Ludwig E and Suttie, Michael},
title = {Facial deformation following treatment for pediatric head and neck rhabdomyosarcoma; the difference between treatment modalities. Results of a trans‐Atlantic, multicenter cross‐sectional cohort study},
journal = {Pediatric Blood & Cancer},
year = {2023},
doi = {10.1002/pbc.30412}
}
EUVIMED